O.16 Current progress and preliminary results with the systemic administration trial of AVI-4658, a novel phosphorodiamidate morpholino oligomer (PMO) skipping dystrophin exon 51 in Duchenne muscular dystrophy (DMD)

✍ Scribed by S.B. Shrewsbury; S. Cirak; M. Guglieri; K. Bushby; F. Muntoni

• Book ID: 116794570
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 48 KB
• Volume: 20
• Category: Article
• ISSN: 0960-8966
• DOI: 10.1016/j.nmd.2010.07.140